Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZX-101A in Advanced Solid Tumors
NCT05258266Phase 2Unknown
- Sponsor
- Zenshine Pharmaceuticals Co., Ltd.
- Start
- Mar 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ZX-101A in solid tumor (advanced stage), sponsored by Zenshine Pharmaceuticals Co., Ltd.. Status: unknown.
02
Drugs
ZX-101A
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT05258266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05258266.